Detalles de la búsqueda
1.
Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial.
Heart Vessels
; 31(11): 1731-1739, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26747438
2.
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.
Lancet
; 383(9915): 413-23, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24183564
3.
Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.
Am Heart J
; 169(1): 69-77, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25497250
4.
Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial.
Catheter Cardiovasc Interv
; 85(4): 524-31, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24753036
5.
Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial.
Catheter Cardiovasc Interv
; 85(3): E76-82, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25339110
6.
Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcome.
Catheter Cardiovasc Interv
; 85(1): 74-81, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24585502
7.
Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): rationale and study design of the randomized TWENTE III multicenter trial.
Am Heart J
; 167(4): 445-51, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24655691
8.
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study.
EuroIntervention
; 11(13): 1487-94, 2016 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26465376
9.
Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial.
EuroIntervention
; 12(4): 431-40, 2016 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26342469
10.
Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From the DUTCH PEERS (TWENTE II) Randomized Trial.
Rev Esp Cardiol (Engl Ed)
; 69(12): 1152-1159, 2016 Dec.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-27595181
11.
Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial.
Clin Res Cardiol
; 105(3): 206-15, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26329584
12.
Fractional flow reserve and coronary bifurcation anatomy: a novel quantitative model to assess and report the stenosis severity of bifurcation lesions.
JACC Cardiovasc Interv
; 8(4): 564-74, 2015 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25819180
13.
Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial.
EuroIntervention
; 10(11): 1276-9, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25136888
14.
Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial.
EuroIntervention
; 11(2): 180-7, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24602919
15.
Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II).
JACC Cardiovasc Interv
; 8(7): 889-99, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26003019
16.
Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registry.
Int J Cardiol
; 176(3): 885-90, 2014 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25168098
17.
Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial.
EuroIntervention
; 10(6): 664-71, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25330500
18.
Single-chain VEGF/Cy5.5 targeting vegf receptors to indicate atherosclerotic plaque instability.
Mol Imaging Biol
; 15(3): 250-61, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23054554
19.
Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial.
J Am Coll Cardiol
; 61(24): 2406-2416, 2013 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23602769
20.
Resultados de los stents Resolute Integrity y Promus Element en el infarto de miocardio: análisis del ensayo aleatorizado DUTCH PEERS (TWENTE II ) / Outcome after myocardial infarction treated with Resolute Integrity and Promus Element stents: insights from the DUTCH PEERS (TWENTE II) randomized trial
Rev. esp. cardiol. (Ed. impr.)
; 69(12): 1152-1159, dic. 2016. graf, tab
Artículo
en Español
| IBECS (España) | ID: ibc-158506